First human trial launches for experimental heart risk drug
Disease control
Recruiting now
This study is the first time MRT-8102, an experimental pill, is being tested in humans. It aims to check the drug's safety in 100 healthy adults and people at risk for heart problems with high CRP levels. Participants will take single or multiple doses of the drug or a placebo ov…
Phase: PHASE1 • Sponsor: Monte Rosa Therapeutics, Inc • Aim: Disease control
Last updated May 19, 2026 12:01 UTC